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Meta-Analysis
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Pneumonia constitutes a substantial disease burden among adults overall and those who are elderly. We aimed to identify all stud-
ies investigating the disease burden among older adults (age, ≥65 years) admitted to the hospital with pneumonia. We estimated 
the hospital admission rate and in-hospital case-fatality ratio (CFR) of pneumonia in older adults, stratified by age and economic 
status (industrialized vs developing), with data from a systematic review of studies published from 1996 through 2017 and from 8 
unpublished population-based studies. We applied these rate estimates to population estimates for 2015 to calculate the global and 
regional burden in older adults who would have been admitted to the hospital with pneumonia that year. We estimated the number 
of in-hospital pneumonia deaths by combining in-hospital CFRs with hospital admission estimates from hospital-based studies. We 
identified 109 eligible studies; 73 used clinical pneumonia as the case definition, and 36 used radiologically confirmed pneumonia as 
the case definition. We estimated that, in 2015, 6.8 million episodes (uncertainty range [UR], 5.8–8.0 episodes) of clinical pneumonia 
resulted in hospital admissions of older adults worldwide. The hospital admission rate increased with advancing age and was higher 
in men. The total disease burden was likely underestimated when using the definition of radiologically confirmed pneumonia. Based 
on data from 52 hospital studies reporting data on pneumonia mortality, we estimated that about 1.1 million in-hospital deaths (UR, 
0.9–1.4 in-hospital deaths) occurred among older adults. The burden of pneumonia requiring hospitalization among older adults is 
substantial. Appropriate prevention and management strategies should be developed to reduce its impact.
Keywords. Pneumonia; older adults; disease burden.
Pneumonia constitutes a substantial disease burden among 
adults overall and those who are elderly. The Global Burden of 
Disease (GBD), Injuries, and Risk Factors Study 2015 estimated 
that, in 2015, lower respiratory tract infections (LRIs) caused 1.2 
million deaths (uncertainty range [UR], 1.0–1.3) and 13.5 mil-
lion disability-adjusted life-years (UR, 11.7–14.4) among adults 
aged ≥65 years [1]. A prospective population-based study across 
multiple centers in the United States described the causes and 
rates of hospitalized community-acquired pneumonia (CAP). 
This study estimated that the hospital admission rate for CAP 
among adults aged ≥18  years was 2.5 cases/1000 persons per 
year and that the highest rates occurred in older adults aged 
65–79 years (6.3 cases/1000 persons per year) and those aged 
≥80 years (16.4 cases/1000 persons per year) [2]. The hospital 
admission rate increased with age. Currently, there are no sys-
tematically established global estimates of the hospitalization 
rate for pneumonia or acute respiratory tract infection (ARI) 
in older adults aged ≥65 years. However, there is a substantial 
quantity of high-quality data on hospitalizations and in-hospital 
mortality from pneumonia among adults worldwide. Therefore, 
we aim to estimate the rate of hospital admissions and in-hos-
pital deaths due to pneumonia in older adults aged ≥65 years 
in 2015, worldwide and stratified by age and economic status 
(industrialized versus developing). Furthermore, we examined 
how these estimates varied by case definition and sex.
METHODS
Search Strategy and Selection Criteria
We conducted a systematic review across 9 databases (including 
3 Chinese-language databases), following the approach detailed 
in the PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) guidelines [3]. Tailored search 
strategies were developed and used to search Medline, Embase, 
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Global Health, CINAHL, Web of Science, LILACS, China 
National Knowledge Infrastructure (CNKI), Wanfang Data, 
and Chongqing VIP databases (Supplementary Table 1). All 
searches were limited to literature between January 1996 and 
September 2017. No publication status criteria or language 
restrictions were applied. We included studies that fulfilled the 
selection criteria in Supplementary Panel 1.
Three investigators (T. S., A.  D., and A.  T.) conducted the 
search in English-language databases and extracted data by 
using standardized data-extraction templates. Any disagree-
ments were resolved after discussion. One investigator (T. S.) 
whose first language is Chinese performed searches and data 
extraction from Chinese-language databases (CNKI, Wanfang, 
and Chongqing VIP). Based on the published studies and our 
knowledge of previously funded/currently ongoing studies, we 
contacted investigators who led studies in the past 15 years on 
hospitalization for pneumonia in older adults, and we identi-
fied unpublished data from 8 studies. The investigator group 
(of collaborators sharing unpublished data with us) agreed on 
a common approach for data analysis and interpretation and 
formulated common case definitions. They used these case defi-
nitions to reanalyze data from their already published work, 
or they shared hitherto unpublished data from ongoing stud-
ies. This method resulted in analysis of additional unpublished 
data, which supplemented and substantially enriched data from 
the review of published studies.
The protocol of this review was published in the PROSPERO 
database (registration CRD42018091423).
Definitions
The definition of pneumonia or ARI in older adults aged 
≥65 years was adapted from the World Health Organization 
(WHO) Integrated Management of Adolescent and Adult 
Illness definitions [4]. The details of the definitions are dis-
played in Supplementary Table 2. Few studies used the ARI 
or LRI definition; therefore, in this article we used the term 
“clinical pneumonia” to include ARI, LRI, CAP, pneumo-
nia, and severe acute respiratory infection (SARI). We cat-
egorized countries as broadly within either industrialized 
or developing regions on the basis of the United Nations 
Children’s Fund’s 2015 classification and used this to report 
our results [5, 6]. The adult population estimates for 2015 
were taken from the United Nations Population Division’s 
database [7].
Statistical Analysis
For all included studies, we expressed the hospital admission 
rate as the number of admissions per 1000 persons per year and 
the in-hospital case-fatality rate (hCFR) as a percentage with 
an accompanying 95% confidence interval (CI), to facilitate 
interpretation and comparison. We applied a continuity cor-
rection of 0.0005 if the number of cases or deaths was 0 [8]. 
This allowed calculation of a hospital admission rate or hCFR 
for these instances and enabled their inclusion in subsequent 
meta-analyses.
We performed meta-analyses by region (classified into 
industrialized versus developing countries) and narrow age 
groups (65–74 years, 75–84 years, and ≥85 years), for the hos-
pital admission rate and hCFR of pneumonia, and reported 
pooled estimates (with 95% CIs). We used the random effects 
model (DerSimonian-Laird method) because in-study and 
between-study data heterogeneity was anticipated and, thus, 
different effect sizes were assumed [9]. The hospital admission 
rate meta-estimate for pneumonia was applied to the regional 
population estimate for individuals aged ≥65  years (by nar-
row age band) to yield estimates for individuals with new epi-
sodes of pneumonia who were admitted to hospitals in 2015. 
We estimated in-hospital pneumonia deaths by applying the 
regional hCFR meta-estimate to the regional number of pneu-
monia-associated hospital admissions (by narrow age bands). 
We estimated URs for in-hospital deaths by using Monte Carlo 
simulation (calculating estimates from 10  000 samples from 
log-normal distributions, with 2.5th and 97.5th centiles defin-
ing the UR). Similar simulations were performed to generate 
the global estimate (from regional estimates) and to estimate 
the overall burden for older adults aged ≥65 years (by summing 
the age-specific estimates) [10].
Data were analyzed using Stata, version 13.0, and R, version 
3.0.2.
RESULTS
We identified 9963 records from the literature search; of these, 
92 articles (101 studies) fulfilled our selection criteria (Figure 
1). Additionally, we identified 8 unpublished studies from the 
investigator group (Supplementary Table 3). Overall, 109 stud-
ies with data on hospital admission and mortality were included 
for further analysis (Supplementary Figure 1). Among them, 73 
studies used the definition of clinical pneumonia confirmed by 
physicians. Of the 73, 49 reported the hospital admission rate 
among older adults aged ≥65 years, and 52 reported mortality 
data. Fifty-seven studies came from industrialized countries, 
and 16 came from developing countries. Thirty-three stud-
ies (46%) were from the WHO Region of the Americas, and 
26 (36%) were from the WHO European Region. Analyses by 
WHO region could not be conducted, owing to a lack of data. 
Twenty studies were from urban areas, 7 were from rural areas, 
and 46 were from a mixed population.
Another 36 studies used the definition of radiologically con-
firmed pneumonia. Of those, 11 reported the hospital admission 
rate among older adults, and 31 reported mortality data. Most 
studies (n = 27) came from industrialized countries, and 9 stud-
ies were from developing countries. Twenty-five studies were in 
urban populations, 1 was in a rural population, and 10 were in 
mixed populations. For our article, the estimates were derived 
from studies using the clinical pneumonia case definition. We 
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used the estimates based on studies with radiologically con-
firmed pneumonia case definition as a comparison group.
For 49 studies reporting the hospital admission rate with 
clinical pneumonia as the definition (Supplementary Table 4), 
the full description of study characteristics and reported data 
are available in Supplementary Table 5. The rate of pneumo-
nia hospitalization in industrialized countries was estimated 
to be 6.8 episodes/1000 persons per year (95% CI, 4.4–10.6) in 
older adults aged 65–74 years, 16.4 episodes/1000 persons per 
year (95% CI, 10.1–26.7) in those 75–84  years, and 34.6 epi-
sodes/1000 persons per year (95% CI, 21.1–56.9) in those aged 
≥85 years. For developing countries, the rate of hospital admis-
sion was estimated to be 4.9 episodes/1000 persons per year 
(95% CI, 3.5–6.7) in older adults aged 65–74 years with pneu-
monia, 14.6 episodes/1000 persons per year (95% CI, 11.2–19.0) 
in those aged 75–84 years, and 45.6 episodes/1000 persons per 
year (95% CI, 32.9–63.1) in those aged ≥85 years. The rate of 
hospital admission increased with age in both industrialized 
and developing countries. The overall number of older adults 
aged ≥65 years with pneumonia who were admitted to the hos-
pital was 6.8 million (UR, 5.8 million–8.0 million), with 3.1 mil-
lion (UR, 2.3 million–4.1 million) in industrialized countries 
and 3.7 million (UR, 3.1 million–4.5 million) in developing 
countries. Seven studies provided data stratified by sex, which 
showed that the rate of hospital admission due to pneumonia 
in older adults aged ≥65  years from industrialized countries 
was 17.3 episodes/1000 persons per year (14.5–20.7) in men 
and 12.9 episodes/1000 persons per year (10.1–16.4) in women. 
Considering that only 1 study reported sex-specific data from 
developing countries, a meta-analysis was not performed.
An increasing trend in the hospitalization rate with advanc-
ing age was also observed in 11 studies in which the definition 
of radiologically confirmed pneumonia was used. Overall, the 
estimated number of radiologically confirmed pneumonia cases 
among older adults aged ≥65 years admitted to hospitals from 
industrialized countries was 2.6 million (UR, 1.3 million–6.0 
million). Similarly, in industrialized countries, the hospitaliza-
tion rate was higher in men than in women, based on only 2 
73 studies reported data on pneumonia 
based on clinical diagnosis:
49 reported hospitalization rate
52 reported mortality 
92 articles included (101
studies)
36 studies reported data on radiologically
confirmed pneumonia (11 reporting 
hospitalization rate and 31 reporting 
mortality)
9960 records identified
through database search
3 records identified
through other sources
8 unpublished studies
1548 duplicates removed
81 full-text articles excluded (list a few main 
exclusion reasons):                 
6 had no data specific to elderly adults,
37 had no relevant data, 
7 had point estimate only, 
9 reported data about a specific pathogen,
3 had data based on statistical modeling, 
3 had only graphical data available, 
7 had no possibility of calculating rate, 
3 studies with a <1-y of follow-up (seasonality), 
4 were posters with limited data, 
2 reported duplicate data 
8415 records screened
173 full-text articles
assessed for eligibility
8242 records excluded
because of irrelevance to topic
Figure 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram of the literature search.
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studies (13.8 episodes/1000 persons per year [95% CI, 12.0–
16.0] vs 7.8 episodes/1000 persons per year [95% CI, 6.6–9.1]). 
There were insufficient data to develop an estimate for develop-
ing countries (0–1 study for narrow age bands) based on radio-
logically confirmed pneumonia.
Of 52 studies reporting mortality data using clinical pneu-
monia as the case definition, 45 reported hCFR, 15 reported 
30-day mortality after admission, and 5 reported 12-month 
mortality after admission. For 45 studies with hCFR data 
(Supplementary Table 6), a full description of the study char-
acteristics and their data are available in Supplementary Table 
7. In industrialized countries, the meta-estimate of hCFR for 
older adults admitted to hospitals with pneumonia was 9.0% 
(95% CI, 7.0%–11.6%) for those aged 65–74 years, 12.1% (95% 
CI, 9.5%–15.4%) for those aged 75–84 years, and 17.5% (95% 
CI, 13.4%–22.7%) for those aged ≥85  years. Similarly, the 
hCFR increased with age in developing countries, with values 
of 13.0% (95% CI, 9.7%–17.4%) in the group aged 65–74 years, 
17.1% (95% CI, 11.8%–24.9%) in the group aged 75–84 years, 
and 22.9% (95% CI, 14.7%–35.7%) in the group aged ≥85 years. 
Across all age bands, the hCFR in developing countries was 
higher than that in industrialized countries, with overlapping 
95% CIs. The overall number of in-hospital deaths in older 
adults aged ≥65  years generated from regional and age-spe-
cific estimates was 1.1 million (UR, 0.9 million–1.4 million) in 
2015, with 0.4 million deaths (UR, 0.3 million–0.6 million) in 
industrialized countries and 0.7 million deaths (UR, 0.5 mil-
lion–1.0 million) in developing countries. Only 2 studies pro-
vided sex-specific data, resulting in hCFRs of 11.6%–11.9% in 
men and 9.8%–10.2% in women. The meta-estimate of 30-day 
mortality after admission for older adults aged ≥65 years with 
pneumonia was 15.9% (95% CI, 13.0%–19.3%) in industrial-
ized countries (11 studies; there were no data for developing 
countries). In addition, the meta-estimate of the 12-month 
mortality after admission was 37.7% (95% CI, 25.3%–56.3%) 
among those aged ≥65  years in industrialized countries (3 
studies).
There were 31 studies reporting mortality data based on 
radiologically confirmed pneumonia as the case definition; 19 
reported hCFRs, 14 reported 30-day mortality after admission, 
and only 1 reported 12-month mortality after admission. Most 
studies only reported the data for the group aged ≥65  years 
without providing narrow age band–specific estimates. 
Therefore, overall in-hospital deaths for older adults with radio-
logically confirmed pneumonia were not calculated, owing to 
missing data in narrow age bands. The meta-estimate of hCFR 
for older adults aged ≥65 years was 9.1% (95% CI, 7.5%–11.1%) 
in industrialized countries and 10.9% (95% CI, 7.3%–16.2%) 
in developing countries. A sex-specific meta-estimate was only 
available in industrialized countries, with a value of 14.3% (95% 
CI, 8.7%–23.7%) in men and 8.5% (95% CI, 5.5%–13.0%) in 
women. The 30-day mortality after admission was 9.1% (95% 
CI, 6.5%–12.7%) in industrialized countries and 8.4% (95% CI, 
3.7%–19.4%) in developing countries.
DISCUSSION
This is the first systematic review to evaluate and summarize 
the available literature and unpublished data on the burden of 
hospitalized pneumonia in older adults aged ≥65  years. Our 
review summarized data from about 17 million cases of pneu-
monia-related hospitalizations in older adults from 101 studies 
reported in 92 articles and 8 unpublished studies. We estimated 
that, in 2015, there were about 6.8 million hospital admissions 
involving in older adults with pneumonia. We further estimated 
that there were about 1.1 million pneumonia-related hospital 
deaths.
Only 25 (23%) of 109 studies reported data from developing 
countries. Estimates from developing countries were missing 
for some WHO regions (the Eastern Mediterranean Region, 
the South-East Asia Region, and much of the African Region), 
as well as for narrower age bands. This is expected because, in 
general, the health information systems in developing coun-
tries do not provide accurate information about the regional 
and national burden of pneumonia on hospital services [11]. 
The hospital admission estimates of pneumonia from develop-
ing countries largely came from studies where the catchment 
population had relatively good access to care and good health-
care-seeking behavior. We expect that many adults with pneu-
monia in developing countries do not receive hospital care [12]. 
Therefore, our global and regional estimates likely underesti-
mate the true burden of pneumonia that should be treated in 
hospitals. Moreover, only 1 study provided a hospital admission 
rate, and 2 reported hCFRs for older adults with very severe 
pneumonia. More studies are needed to better understand the 
burden of very severe pneumonia in older adults. Although our 
results suggested that men had higher a hospital admission rate 
and hCFR, the number of available studies was limited, and 
conclusions can be drawn only for the entire group of adults 
aged ≥65 years. More studies with sex-specific data are required 
to provide robust evidence regarding sex-based differences.
Our estimates vary widely among regions and study sites. 
Comparisons among studies should be interpreted with cau-
tion because several factors may affect the estimates: differences 
in enrollment criteria, case definitions, demographic charac-
teristics, geographical location of the study sites, surveillance 
methods, temporal variability in pneumonia incidence, cul-
tural factors, and healthcare-seeking behavior of the underly-
ing population. Therefore, the true uncertainties around these 
estimates may be larger than those expressed in the standard 
95% CIs that we report.
Our findings suggest that the number of hospital admissions 
among individuals aged ≥65  years in industrialized countries 
was comparable to the number of admissions in developing 
countries (ie, 3.1 million and 3.7 million, respectively). This 
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may be partially explained by the high proportion of older 
adults and low thresholds for hospital admission in industri-
alized countries and poor care-seeking behavior in developing 
countries. However, the hCFR in industrialized countries was 
lower than that reported for developing countries (although 
with overlapping 95% CIs). These findings suggest that patients 
in industrialized countries have better access to high-quality 
healthcare facilities.
GBD 2015 studies estimate that the overall number of cases 
and deaths from LRIs in older adults aged ≥65 years were 78.8 
million (95% uncertainty interval [UI], 72.5 million–84.8 mil-
lion) and 1.2 million (95% UI, 1.0 million–1.3 million), respec-
tively [1, 13]. We, however, estimated that, in 2015, there were 
6.8 million pneumonia hospitalizations (UR, 5.8 million–8.0 
million) and 1.1 million in-hospital deaths (UR, 0.9 million–1.4 
million). Although these data are not strictly comparable owing 
to the different modeling methods used, they may be consis-
tent with the interpretation that a majority of pneumonia cases 
(approximately 91%) were not hospitalized, while most deaths 
associated with pneumonia (approximately 92%) occurred in 
hospitals. This result is probably due to the large difference in 
CFR between hospital-based and outside-hospital pneumonia 
cases, the fact that most older adults with pneumonia from 
developing countries are not admitted, and possible underesti-
mation of mortality from GBD estimates.
Developing standardized pneumonia definitions for epide-
miological research and clinical trials is challenging. Among the 
included 109 studies, 73 reported data on an outcome that we 
included as clinical pneumonia (including CAP, ARI [in 3 stud-
ies], LRI [in 2], and SARI [in 1]), which was based on symptoms 
and signs, International Classification Diseases, Ninth Revision, 
Clinical Modification (ICD-9CM) discharge codes 480–486, or 
ICD-10 discharge codes J10–J18. Another 36 studies reported 
radiologically confirmed pneumonia. Our final estimates for 
all-cause pneumonia were based on the 73 studies using clin-
ical pneumonia as the case definition, because we found sub-
stantial differences in estimates between the clinical pneumonia 
and radiologically confirmed pneumonia case definitions. Both 
the hospitalization rate and the number of hospitalized cases of 
radiologically confirmed pneumonia were smaller than those 
using the definition of all-cause clinical pneumonia. This is con-
sistent across all age groups, indicating that, by using the defi-
nition of radiologically confirmed pneumonia, the burden of 
pneumonia in hospitals was likely substantially underestimated. 
Therefore, when limiting the analysis to older adults with radio-
logically confirmed pneumonia, we may have underestimated 
the disease burden because only a proportion of adults with 
clinical pneumonia had chest radiographs (eg, 50% in the 
study by Prapasiri et al and 60% in the study by Watt et al) [14, 
15]. One study in our review presented the hospital admission 
data for both clinical and radiologically confirmed pneumonia 
[15]. This study observed that the hospitalization rate in older 
adults aged ≥65 years was substantially lower when radiolog-
ically confirmed CAP was used as the case definition (30.3 vs 
62.2 episodes/1000 persons per year). This difference may be 
because some pneumonia cases do not have radiographic find-
ings. The presence of chronic lung disease, including tubercu-
losis, can complicate the radiographic diagnosis of pneumonia. 
Significant variability also exists between reviewers in inter-
preting chest radiography findings [15]. In addition, since the 
definition of pneumonia was based on clinical and radiological 
criteria, the features could overlap with those from other con-
ditions (eg, chronic lung disease and congestive heart failure). 
Finally, the percentage of diagnosed cases in which pathogen 
isolation was performed was usually low; thus, there is a possi-
bility of misclassification of pneumonia.
We found that pneumonia hospitalization rates and hCFRs 
increased with age, as discussed in other studies [16]. This 
indicates that age might be a risk factor for pneumonia in 
adults. However, the majority of older adults included in our 
study had underlying medical conditions, which are associated 
with an increased risk of pneumonia and poor outcome. The 
study by McLaughlin et  al [17] reported the hospital admis-
sion rate among individuals with CAP, which increased from 
low-risk adults (ie, those who were immunocompetent without 
chronic medical conditions) to moderate-risk adults (ie, those 
who were immunocompetent with ≥1 chronic medical condi-
tion), with the highest rate among high-risk adults (ie, those 
who were immunocompromised). Thus, comorbidities should 
be taken into consideration when evaluating the role of age in 
pneumonia hospitalizations. Most studies included a mixture of 
participants with or without comorbidities and did not report 
comorbidity-specific disease burdens. One study presented 
hCFRs for patients with and those without diabetes mellitus 
(18.7% and 21.3%, respectively) [18]. Further research into 
the high-risk profiles of older adults admitted to hospitals with 
severe or very severe pneumonia could help guide prevention 
and management strategies.
In conclusion, this study reviews the existing evidence 
regarding the burden of pneumonia resulting in hospitalization 
among older adults aged ≥65 years. Pneumonia is a common 
and severe disease among older adults. Appropriate preventive 
and therapeutic interventions should be developed to address 
the specific pathogens causing pneumonia, to minimize the dis-
ease burden.
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